© All rights reserved to Barnea Jaffa Lande Law offices

Together is empowering

Search by Practice

Insights & News /  Capital Markets

August 29, 2017

Dr. Zvi Gabbay Interviewed by Walla! about Investigation into Former Bank Leumi Officials

Dr. Zvi Gabbay, head of the Capital Markets Department at our firm, was interviewed by Walla! about a criminal investigation opened against former Bank Leumi officials in a US tax fraud scandal. Zvi believes American investigators will work closely with Israeli investigators on this case, via the international legal aid apparatus at the Justice Ministry.

August 29, 2017

TheMarker Op-Ed: Regulation of Digital Coins

An op-ed in The Marker on the regulation of digital currencies asserts that there will be no choice but to build a unique regulatory model that matches the characteristics of these new financial instruments.

August 16, 2017

TheMarker Interview: SEC Allegations against Mobileye Founders

The US Securities and Exchange Commission (SEC) recently filed a lawsuit in a US court against an Israeli citizen and an American citizen for the use of insider information to acquire shares and options at Mobileye. The lawsuit alleges that Mobileye's founders supplied information about the huge deal being forged between it and Intel. Our firm was interviewed by TheMarker about the lawsuit, and we noted the differences between the enforcement process in Israel and the US and the relationship between civil enforcement by the SEC and criminal enforcement by federal prosecution.

August 8, 2017

Monetary Authority of Singapore to Begin Regulating the Issuance of Virtual Currencies

Adv. Daniel Israeli was interviewed by TheMarker after the Monetary Authority of Singapore (MAS) announced it would begin regulating the issuance of virtual currencies (ICO). Daniel noted that Singapore has developed into a destination of sorts for ICOs, and thus the MAS' decision will certainly change the rules of the game.

July 2, 2017

Barnea & Co. Represented Avgol in the Sale of its Rights in the Barkan Plant

Barnea represented Avgol in the sale of its rights in the Barkan plant for NIS 52.5 million. Avgol is in the process of transfering its production center in Israel to Dimona.

June 22, 2017

Interview with Financial Radio Program on Bezeq Investigation

We were interviewed on a financial radio program on the Public Broadcasting Corporation regarding the Bezeq investigation, where we provided an explanation of the Israel Securities Authority process (from 12.06).

June 20, 2017

Interview with Channel 2 News

We were interviewed on a daily Channel 2 News program focusing on economic and consumer matters following the investigation opened by the Israel Securities Authority against Bezeq. During the interview, we explained the ISA's allegations and its reason for initiating the investigation.

June 20, 2017

Interview on Radio Program "Where Is the Money"

We were interviewed on "Where Is the Money," a program on the 103FM radio station, following the investigation launched by the Israel Securities Authority against Bezeq, its controlling shareholder Shaul Elovitch, and senior officers on suspicion of offenses under the Securities Law. We explained the meaning of related-party transactions in a company (from 11.38).

May 23, 2017

IFX Expo Cyprus 2017 – Regulatory Panel

We are participating today in a regulatory panel held as part of the IFX Expo Cyprus 2017. The panel will discuss recent decisions taken by key regulators, consider their implications, and seek to predict what the future may hold for the industry.

April 19, 2017

SEC Charges Two Israeli Residents with Insider Trading – Opinion Article

We published an op-ed on the US Securities and Exchange Commission's (SEC) decision to file a civil action in a federal court against two Israeli residents who traded in Mobileye stock and options before and after the announcement of its merger with Intel Corp. We noted that the SEC's case against the two Israelis, on suspicion of insider trading, is largely circumstantial.

April 5, 2017

Barnea & Co. represented Avgol in issuance of a New Series of Bonds

Barnea represented Avgol Industries 1953 Ltd in connection with the issuance of a new series of bonds in the amount of NIS 197 Million. Avgol is one of the biggest manufacturers in the world of non-woven fabrics for the hygiene market. Its securities are traded in the leading indices on the Tel Aviv Stock Exchange.

April 4, 2017

Hong Kong Stock Exchange Formally Approves Israel as Acceptable Jurisdiction

We were interviewed by The Marker following the Hong Kong Stock Exchange's (HKSE) approval of Israel as an "acceptable jurisdiction." We noted that the HKSE’s approval is currently limited to Israeli public companies already listed on a foreign exchange and Israeli private companies seeking to list on the HKSE, and that it may also result in cost savings for such companies.

March 27, 2017

Medigus Ltd. Completes NASDAQ IPO

Barnea represented a group of US underwriters, led by H.C. Wainwright, LLC, in the process of submitting Medigus Ltd.'s prospectus for the NASDAQ listing. Medigus raised USD 7.5 million and will be traded on Nasdaq in parallel with its listing on the Tel Aviv Stock Exchange. Medigus Ltd is an Israel-based company active in the medical sector. It specializes in developing endoscopic procedures and devices.

March 15, 2017

Israel Bar Association Training Course for Directors

We lectured today on the Israel Securities Authority as part of the Israel Bar Association's training course for directors.

March 7, 2017

ISA Proposes Prohibiting the Management and Operation of Binary Options Trading Platforms Outside Israel

An op-ed in Financial Magnates following a new proposed bill to prohibit the management and operation of binary options trading platforms outside of Israel, even if regulated elsewhere.

November 30, 2016

Regulation of Crowdfunding in the UK, US, and Israel: Comparative Review

We published a comparative review in Butterworths Journal of International Banking and Financial Law on the regulation of crowdfunding. The article examines how three jurisdictions—the United Kingdom, the United States, and Israel—have addressed the regulatory aspects of the equity crowdfunding sector, and compares the different approaches adopted by their regulators.

February 7, 2017

The CEO of Kitov Pharmaceuticals was Investigated by the Israeli Security Authority on Suspicion of Fraud and False Reporting

Adv. Zohar Lande and Moran Bickel from the Litigation Department at Barnea represented the CEO of Kitov Pharmaceuticals at a hearing in the Tel Aviv Magistrates Court relating to his release from detention, subject to certain restrictive conditions.

January 26, 2017

Panel Discussion on Administrative Enforcement in Haaretz's "Echad Haa'm"

We participated in a panel discussion on administrative enforcement published in Haaretz's "Echad Haa'm," the magazine of the Public Companies Association. The panel addressed the implications of administrative enforcement for the market, as well as its impact on corporate governance standards and company conduct (pp. 16-21).

January 25, 2017

US Federal Trade Commission Investigating Allergan’s Generics Business

We interviewed by Globes after the Federal Trade Commission launched an investigation into a company affiliated with Teva. 

January 10, 2017

Micky Barnea in an Interview by Globes regarding Executive Pay in the Finance Sector and regarding Concessions from the Tel Aviv Stock Exchange and the Israel Securities Authority

Micky Barnea, our Managing Partner, was interviewed by Globes regarding executive pay in the finance sector. He also interviewed on concessions granted by the Tel Aviv Stock Exchange and the Israel Securities Authority. Micky commented that the Tel Aviv Stock Exchange and the Israel Securities Authority have granted a set of concessions to encourage more companies to go public. However, according to Micky, as regards the issue of regulation, the exemptions should be more significant.

    // load AI chatbot on test page